Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 1
1988 1
1989 2
1990 3
1991 2
1992 3
1993 2
1994 1
1995 1
1997 1
1998 1
1999 4
2000 1
2001 4
2002 4
2003 1
2004 1
2006 4
2007 6
2008 3
2009 19
2010 32
2011 23
2012 19
2013 35
2014 32
2015 27
2016 17
2017 15
2018 29
2019 26
2020 20
Text availability
Article attribute
Article type
Publication date

Search Results

264 results
Results by year
Filters applied: . Clear all
Page 1
[French ccAFU guidelines - Update 2018-2020: Prostate cancer].
Rozet F, Hennequin C, Beauval JB, Beuzeboc P, Cormier L, Fromont-Hankard G, Mongiat-Artus P, Ploussard G, Mathieu R, Brureau L, Ouzzane A, Azria D, Brenot-Rossi I, Cancel-Tassin G, Cussenot O, Rebillard X, Lebret T, Soulié M, Renard Penna R, Méjean A. Rozet F, et al. Among authors: Ploussard G. Prog Urol. 2018 Nov;28 Suppl 1:R81-R132. doi: 10.1016/j.purol.2019.01.007. Epub 2019 Aug 23. Prog Urol. 2018. PMID: 31610875 French.
Management of non-metastatic castrate-resistant prostate cancer: A systematic review.
Loriot Y, Supiot S, Beauval JB, Schlürmann F, Pasticier G, Sargos P, Barthélémy P, Pignot G, Maillet D, Vincendeau S, Gross E, Ploussard G, Timsit MO, Borchiellini D. Loriot Y, et al. Among authors: Ploussard G. Cancer Treat Rev. 2018 Nov;70:223-231. doi: 10.1016/j.ctrv.2018.09.006. Epub 2018 Sep 21. Cancer Treat Rev. 2018. PMID: 30300771 Review.
Hereditary prostate cancer - Primetime for genetic testing?
Heidegger I, Tsaur I, Borgmann H, Surcel C, Kretschmer A, Mathieu R, Visschere P, Valerio M, van den Bergh RCN, Ost P, Tilki D, Gandaglia G, Ploussard G; EAU-YAU Prostate Cancer Working Party. Heidegger I, et al. Among authors: Ploussard G. Cancer Treat Rev. 2019 Dec;81:101927. doi: 10.1016/j.ctrv.2019.101927. Epub 2019 Nov 11. Cancer Treat Rev. 2019. PMID: 31783313 Review.
Systemic treatments for high-risk localized prostate cancer.
Pignot G, Maillet D, Gross E, Barthelemy P, Beauval JB, Constans-Schlurmann F, Loriot Y, Ploussard G, Sargos P, Timsit MO, Vincendeau S, Pasticier G, Borchiellini D. Pignot G, et al. Among authors: Ploussard G. Nat Rev Urol. 2018 Aug;15(8):498-510. doi: 10.1038/s41585-018-0017-x. Nat Rev Urol. 2018. PMID: 29765147 Review.
Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study.
Ploussard G, Beauval JB, Lesourd M, Manceau C, Almeras C, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M. Ploussard G, et al. Among authors: Almeras C, Gautier JR, Loison G, Salin A, Tollon C. World J Urol. 2019 Oct 14. doi: 10.1007/s00345-019-02973-7. Online ahead of print. World J Urol. 2019. PMID: 31612251
Added Value of Concomitant Systematic and Fusion Targeted Biopsies for Grade Group Prediction Based on Radical Prostatectomy Final Pathology on Positive Magnetic Resonance Imaging.
Ploussard G, Beauval JB, Lesourd M, Almeras C, Assoun J, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M. Ploussard G, et al. Among authors: Almeras C, Gautier JR, Loison G, Salin A, Tollon C. J Urol. 2019 Dec;202(6):1182-1187. doi: 10.1097/JU.0000000000000418. Epub 2019 Jun 27. J Urol. 2019. PMID: 31246548
Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now?
Tsaur I, Heidegger I, Kretschmer A, Borgmann H, Gandaglia G, Briganti A, de Visschere P, Mathieu R, Valerio M, van den Bergh R, Ost P, Mirvald C, Tilki D, Ploussard G, Surcel C; EAU-YAU Prostate Cancer Working Party. Tsaur I, et al. Among authors: Ploussard G. Cancer Treat Rev. 2019 May;75:20-26. doi: 10.1016/j.ctrv.2019.03.001. Epub 2019 Mar 11. Cancer Treat Rev. 2019. PMID: 30875581 Review.
Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review.
Ploussard G, Gandaglia G, Borgmann H, de Visschere P, Heidegger I, Kretschmer A, Mathieu R, Surcel C, Tilki D, Tsaur I, Valerio M, van den Bergh R, Ost P, Briganti A; EAU-YAU Prostate Cancer Working Group. Ploussard G, et al. Eur Urol. 2019 Oct;76(4):493-504. doi: 10.1016/j.eururo.2018.10.041. Epub 2018 Oct 31. Eur Urol. 2019. PMID: 30391078 Review.
Impact of abiraterone acetate plus prednisone or enzalutamide on fatigue and cognition in patients with metastatic castration-resistant prostate cancer: initial results from the observational AQUARiUS study.
Thiery-Vuillemin A, Poulsen MH, Lagneau E, Ploussard G, Birtle A, Dourthe LM, Beal-Ardisson D, Pintus E, Trepiakas R, Antoni L, Lukac M, Van Sanden S, Pissart G, Reid A. Thiery-Vuillemin A, et al. Among authors: Ploussard G. ESMO Open. 2018 Aug 3;3(5):e000397. doi: 10.1136/esmoopen-2018-000397. eCollection 2018. ESMO Open. 2018. PMID: 30116592 Free PMC article.
264 results
Jump to page
Feedback